Traws Pharma, Inc.
TRAW
$1.88
$0.021.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -915.00K | 21.49M | -29.92M | -8.48M | -123.14M |
| Total Depreciation and Amortization | 1.00K | 1.00K | 2.00K | 2.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.00K | -26.35M | 24.77M | 343.00K | 117.84M |
| Change in Net Operating Assets | -5.02M | -576.00K | 1.11M | -3.35M | -4.56M |
| Cash from Operations | -5.98M | -5.44M | -4.04M | -11.48M | -9.85M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -3.65M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -3.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.26M | 136.00K | 19.98M | 0.00 | 14.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -164.00K | -123.00K | -- | -- | -- |
| Cash from Financing | 3.10M | 13.00K | 19.98M | 0.00 | 14.00M |
| Foreign Exchange rate Adjustments | 28.00K | 23.00K | -9.00K | 0.00 | -3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.86M | -5.40M | 15.93M | -11.48M | 496.00K |